Argenx stock pre-market at EUR 857.20: minus 0.08 percent
Published on 09/30/2026 at 08:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Argenx stock was at EUR 857.20 pre-market at 8:30 a.m. CEST on September 30, 2026, according to Lang & Schwarz. The price was down EUR 0.70, or 0.08 percent, versus the prior close of EUR 857.90.
Pre-market indication
Lang & Schwarz showed a bid of EUR 853.60 and an ask of EUR 860.80 at the quoted time. The price indication is separate from the company's reported developments.
Vyvgart and pipeline presentations
A September 29 report said argenx SE announced clinical, long-term and real-world data presentations at the AANEM Annual Meeting and the MGFA Scientific Session in Orlando, scheduled from September 29 through October 2. The report said the presentations cover VYVGART in myasthenia gravis and chronic inflammatory demyelinating polyradiculoneuropathy, along with empasiprubart and adimanebart. Ideal Investisseur reported the details.
